CVS HEALTH Corp (CVS) operating KPIs
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)
Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%
Cvs Health centene Corporation (CNC) — Medical Costs ($M)
Quarterly figures from Cvs Health's filings and investor materials
Latest, Q3 2026
41,128
Period ended Sep 30, 2026
Change on a year earlier
+0.6%
40,902 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
2
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Centene Corporation (CNC) — Medical Costs ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 41,128 | +0.6% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2026 | Jun 30, 2026 | 39,029 | +0.6% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2026 | Mar 31, 2026 | 38,303 | +4.9% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2025 | Dec 31, 2025 | 41,489 | +30.4% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2025 | Sep 30, 2025 | 40,902 | +27.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2025 | Jun 30, 2025 | 38,808 | +26.1% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2025 | Mar 31, 2025 | 36,503 | +18.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2024 | Dec 31, 2024 | 31,809 | +3.8% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2024 | Sep 30, 2024 | 32,201 | +9.2% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2024 | Jun 30, 2024 | 30,765 | +4.8% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2024 | Mar 31, 2024 | 30,932 | +5.1% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2023 | Dec 31, 2023 | 30,634 | +8.4% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2023 | Sep 30, 2023 | 29,479 | +4.9% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2023 | Jun 30, 2023 | 29,347 | +7.5% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2023 | Mar 31, 2023 | 29,434 | +5.7% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2022 | Dec 31, 2022 | 28,268 | +11.3% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2022 | Sep 30, 2022 | 28,111 | +10.5% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2022 | Jun 30, 2022 | 27,312 | +12.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2022 | Mar 31, 2022 | 27,838 | +19.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2021 | Dec 31, 2021 | 25,392 | +12.3% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2021 | Sep 30, 2021 | 25,430 | +10.9% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2021 | Jun 30, 2021 | 24,389 | +20.1% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2021 | Mar 31, 2021 | 23,391 | +14.5% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2020 | Dec 31, 2020 | 22,605 | +48.5% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2020 | Sep 30, 2020 | 22,932 | +48.9% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2020 | Jun 30, 2020 | 20,307 | +41.5% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2020 | Mar 31, 2020 | 20,420 | +47.1% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2019 | Dec 31, 2019 | 15,220 | +17.0% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2019 | Sep 30, 2019 | 15,406 | +22.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2019 | Jun 30, 2019 | 14,354 | +38.3% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2019 | Mar 31, 2019 | 13,882 | +38.3% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2018 | Dec 31, 2018 | 13,012 | +35.9% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2018 | Sep 30, 2018 | 12,626 | +32.3% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2018 | Jun 30, 2018 | 10,380 | +10.3% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2018 | Mar 31, 2018 | 10,039 | +7.7% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2017 | Dec 31, 2017 | 9,573 | +11.8% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2017 | Sep 30, 2017 | 9,543 | +13.9% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2017 | Jun 30, 2017 | 9,413 | +12.3% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2017 | Mar 31, 2017 | 9,322 | +75.5% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2016 | Dec 31, 2016 | 8,564 | – | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2016 | Sep 30, 2016 | 8,376 | – | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2016 | Jun 30, 2016 | 8,385 | – | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2016 | Mar 31, 2016 | 5,311 | – | Centene Corp. SEC 10-Q (XBRL) ↗ |
Cite this data
StockData. (2026). Cvs Health Centene Corporation (CNC) — Medical Costs ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer_cnc_benefits
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.